(function(){ var content_array=["

A<\/strong>bout <\/strong>Hong Kong Biotechnology Organization<\/strong><\/p>\r\n

Founded by pioneering scientists with extensive life science backgrounds and multi-cultural experience in research and development, engineering and business in 2009, the Hong Kong Biotechnology Organization (HKBIO) is an independent non-profit organization with the goal to promote best practice, raise awareness across the biotechnology industry while providing added value benefits to its members, whether they are students, researchers, entrepreneurs, industry bodies, public or private sector representatives. HKBIO focuses on establishing and facilitating a worldwide platform for the Hong Kong biotech industry, promoting awareness, encouraging and enabling international collaboration and providing informed opinion and technical advice to government bodies, healthcare institutions and the general public.<\/p>\r\n

About Asia Fund for Cancer Research<\/strong><\/p>\r\n

The Asian Fund for Cancer Research, Ltd. (AFCR) is a charity registered in Hong Kong that supports innovative, leading-edge research to accelerate the development of new cancer therapeutics and make these treatments more accessible to cancer patients worldwide. AFCR also provides prevention education publications to help people in Asia, particularly those in the Greater China area, to better protect themselves against cancer. AFCR commits to curing cancers that have significant impacts on Asian populations. Headquartered in Hong Kong, AFCR is uniquely positioned to implement in Asia the newest cancer research discoveries and technologies from around the world, investigate the distinct causes of cancer in Asian populations through innovative genetic and molecular research, and develop more effective therapies tailored to Asian cancer patients. AFCR is dedicated to bridging the scientific and educational gaps in cancer research and cancer prevention between Asian countries and the rest of the world through promoting, coordinating and funding international collaboration in cancer research and public education. We are fully devoted to reducing the incidence and increasing the survival rate of cancers in Asia.<\/p>"]; $("#dvExtra").html(content_array[0]);})();